JP2022537994A5 - - Google Patents

Info

Publication number
JP2022537994A5
JP2022537994A5 JP2021575050A JP2021575050A JP2022537994A5 JP 2022537994 A5 JP2022537994 A5 JP 2022537994A5 JP 2021575050 A JP2021575050 A JP 2021575050A JP 2021575050 A JP2021575050 A JP 2021575050A JP 2022537994 A5 JP2022537994 A5 JP 2022537994A5
Authority
JP
Japan
Prior art keywords
disease
formula
compound
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021575050A
Other languages
English (en)
Japanese (ja)
Other versions
JP7618597B2 (ja
JP2022537994A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/068181 external-priority patent/WO2021001286A1/en
Publication of JP2022537994A publication Critical patent/JP2022537994A/ja
Publication of JP2022537994A5 publication Critical patent/JP2022537994A5/ja
Application granted granted Critical
Publication of JP7618597B2 publication Critical patent/JP7618597B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021575050A 2019-07-01 2020-06-29 D1ポジティブアロステリックモジュレーターとしての置換されたテトラヒドロイソキノリン誘導体 Active JP7618597B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19183641.0 2019-07-01
EP19183641 2019-07-01
PCT/EP2020/068181 WO2021001286A1 (en) 2019-07-01 2020-06-29 A substituted tetrahydroisoquinoline derivative as a d1 positive allosteric modulator

Publications (3)

Publication Number Publication Date
JP2022537994A JP2022537994A (ja) 2022-08-31
JP2022537994A5 true JP2022537994A5 (cg-RX-API-DMAC7.html) 2023-07-04
JP7618597B2 JP7618597B2 (ja) 2025-01-21

Family

ID=67137842

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021575050A Active JP7618597B2 (ja) 2019-07-01 2020-06-29 D1ポジティブアロステリックモジュレーターとしての置換されたテトラヒドロイソキノリン誘導体

Country Status (28)

Country Link
US (1) US12358890B2 (cg-RX-API-DMAC7.html)
EP (1) EP3993795B1 (cg-RX-API-DMAC7.html)
JP (1) JP7618597B2 (cg-RX-API-DMAC7.html)
KR (1) KR102949226B1 (cg-RX-API-DMAC7.html)
CN (1) CN114008032B (cg-RX-API-DMAC7.html)
AR (1) AR119317A1 (cg-RX-API-DMAC7.html)
AU (1) AU2020299705B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021022379A2 (cg-RX-API-DMAC7.html)
CA (1) CA3139622A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021002949A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021017740A2 (cg-RX-API-DMAC7.html)
EC (1) ECSP22007557A (cg-RX-API-DMAC7.html)
ES (1) ES3069145T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20260599T1 (cg-RX-API-DMAC7.html)
IL (1) IL289317B2 (cg-RX-API-DMAC7.html)
MA (1) MA56445B1 (cg-RX-API-DMAC7.html)
MX (1) MX2021015872A (cg-RX-API-DMAC7.html)
MY (1) MY210362A (cg-RX-API-DMAC7.html)
PE (1) PE20220373A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021552819A1 (cg-RX-API-DMAC7.html)
PL (1) PL3993795T3 (cg-RX-API-DMAC7.html)
RS (1) RS68243B1 (cg-RX-API-DMAC7.html)
SA (1) SA521431274B1 (cg-RX-API-DMAC7.html)
SG (1) SG11202112539XA (cg-RX-API-DMAC7.html)
TW (1) TWI842923B (cg-RX-API-DMAC7.html)
UA (1) UA130613C2 (cg-RX-API-DMAC7.html)
WO (1) WO2021001286A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202109194B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020131671A1 (en) 2018-12-18 2020-06-25 Eli Lilly And Company Dose regimens for use of ly3154207 in the treatment of dopaminergic cns disorders
EP4200280B1 (en) 2020-10-07 2024-02-21 Eli Lilly And Company Phenyl-3,4-dihydroisoquinolin-2(1h)-yl-ethan-1-one derivatives as dopamine d1 receptor positive allosteric modulators
CN117337173A (zh) * 2021-03-09 2024-01-02 伊莱利利公司 美维达林和其他d1正向别构调节剂用于减缓帕金森氏病进展的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010520217A (ja) 2007-03-01 2010-06-10 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒスタミンh3受容体のモジュレーターとしてのテトラヒドロイソキノリン化合物
KR101284796B1 (ko) 2011-10-05 2013-07-10 (주)포인트엔지니어링 캔 패지키 타입의 광 디바이스 제조 방법 및 이에 의해 제조된 광 디바이스
US9278960B2 (en) 2011-11-03 2016-03-08 Merck Sharp & Dohme Corp. Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
JO3316B1 (ar) 2013-05-30 2019-03-13 Lilly Co Eli مركبات 3، 4-داي هيدرو أيزو كوينولين -2(1h)-يل
EA035544B1 (ru) 2014-10-08 2020-07-03 Юсб Байофарма Спрл Производные тетрагидроизохинолина
CN108884050B (zh) * 2016-04-13 2022-07-05 Ucb生物制药私人有限公司 四氢异喹啉衍生物
EP3596060B1 (en) * 2017-03-16 2023-09-20 F. Hoffmann-La Roche AG New bicyclic compounds as atx inhibitors
TWI725408B (zh) 2018-04-20 2021-04-21 美商美國禮來大藥廠 多巴胺d1受體正向異位調節劑

Similar Documents

Publication Publication Date Title
JP2022539152A5 (cg-RX-API-DMAC7.html)
US10526303B2 (en) 7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto
JP2022191257A5 (cg-RX-API-DMAC7.html)
CA2528160A1 (en) Use of 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl) piperazine for neuronal regeneration and functional recovery
JP2009511568A5 (cg-RX-API-DMAC7.html)
JP2002501025A5 (cg-RX-API-DMAC7.html)
JP2013536833A5 (cg-RX-API-DMAC7.html)
JP2012530779A5 (cg-RX-API-DMAC7.html)
JP2004534816A5 (cg-RX-API-DMAC7.html)
RU2010129929A (ru) Производные 5-оксо-3-пирролидинкарбоксамида в качестве модуляторов р2х7
TW201622721A (zh) S1p調節劑之立即釋放劑量療法
JP2018507886A5 (cg-RX-API-DMAC7.html)
JP2017511339A5 (cg-RX-API-DMAC7.html)
JP2019512469A5 (cg-RX-API-DMAC7.html)
JP2022519744A5 (cg-RX-API-DMAC7.html)
JP2010513250A5 (cg-RX-API-DMAC7.html)
JP2021530543A5 (cg-RX-API-DMAC7.html)
CA2494010A1 (en) Modafinil polymorphic forms
JP2005508872A5 (cg-RX-API-DMAC7.html)
JP2001523716A5 (cg-RX-API-DMAC7.html)
CO6290669A2 (es) Usos terapeuticos de compuestos que tiene afinidad con el transportador de serotonina los receptores de serotonina y transportador de noraadrenalina
JP2023518640A5 (cg-RX-API-DMAC7.html)
JP2024511053A5 (cg-RX-API-DMAC7.html)
JP2005517634A5 (cg-RX-API-DMAC7.html)
HRP20241657T1 (hr) Supstituirani derivat tetrahidroizokinolina kao d1 pozitivni alosterički modulator